A method for detecting substances related to thio-oligonucleotides
By reverse phase ion pair liquid chromatography combined with specific chromatography columns and mobile phase composition, the problem of difficult separation of impurities in shortened sequence and incomplete sulfide sequence in thiooligonucleotide YK102 is solved, achieving high reproducibility and effective impurity monitoring to meet drug quality control requirements.
Patent Information
- Application Number
- CN202111671870.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-31
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2041-12-31
AI Technical Summary
The prior art is difficult to effectively isolate and monitor shortened sequence (n-1) impurities and incomplete thio sequence impurities in the thio oligonucleotide YK102, especially the separation ability of 5'n-1 and 3'n-1 impurities is weak. , poor reproducibility and affect drug quality control.
Reverse phase ion pair liquid chromatography was used with Waters XBridge Oligonucleotide BEH C18 chromatography column, mobile phase was 1,1,1,3,3-hexafluoro-2-methyl-2-propanol/N,N -Dimethylbutylamine/hexylamine-methanol mixed solution, column temperature 60-80℃, flow rate 0.2-0.5mL/min, detection wavelength 256-264nm, and the baseline of impurities and main peaks is achieved by optimizing the elution gradient and mobile phase composition. When separated, the separation degree between impurities is greater than 1.2.
The effective separation of shortened sequence and incomplete sulfur sequence impurities in YK102 raw materials was achieved, with good reproducibility, with a resolution of impurities and main peaks greater than 1.5, and a resolution of impurities greater than 1.2, meeting the needs of drug quality control.
Smart Images

Figure CN114414712B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of drug detection, and particularly relates to a method for detecting single-base deletion sequence impurities and incomplete thio-sequence impurities in a thio-oligonucleotide YK102 raw material drug. Background Art
[0002] Antisense oligonucleotides (ASODN) are artificially synthesized single-stranded DNA or RNA fragments that can bind to specific target mRNA or target DNA through Watson-Crick base complementary pairing to inhibit or block the transcription and expression of the gene. They can be used to treat a variety of diseases such as viral infectious diseases, cardiovascular diseases, and cancer, and are more specific and efficient than traditional drugs. Thiothioate-modified oligonucleotides, that is, a sulfur atom replaces a non-bridging oxygen atom in the phosphate group, can increase the resistance of oligonucleotides to ribozymes. RNase H refers to ribonuclease H, which is an endoribonuclease that can specifically hydrolyze RNA in DNA-RNA hybrid chains. Oligonucleotides hybridize with target mRNA, activate RNase H, degrade target mRNA, and block overexpression of target genes, which has a good prospect for pharmaceutical applications.
[0003] The impurities in the synthesis process of phosphorothioate oligonucleotides are mainly composed of short sequences and phosphorothioate failure sequences, among which the 5N′-1 sequence and the N sequence with one oxygen not replaced by sulfur (P=S / O) are the most common. Since the impurities are very similar to the main component structure, it is very difficult to separate them. Anion exchange chromatography is usually used to analyze P=S / O impurities and other impurities, but ion exchange chromatography is powerless for N-1 impurities, and capillary electrophoresis is required to analyze N-1 impurities [Yang Hongmiao, Fan Huihong, Progress in the analysis of oligonucleotide drugs by reversed-phase ion pair chromatography, Chinese Journal of Biochemical Pharmacology, 2015, 35(7), 161~164; Zhang Hongyan et al., Analysis of the related substances in phosphorothioateantisenseoligonucleotide FT19, Chin J Chromatogr, 2008, 26(5):540–543], but capillary electrophoresis has poor reproducibility and weak separation ability.
[0004] YK102 is a thio-oligonucleotide drug targeting insulin-like growth factor type I receptor (IGF-1R) that is currently under clinical research. The sequence is 20 bases long and its nucleotide sequence is 5'-TCCTCCGGAGCCAGACTTCA-3'. The drug has good anti-tumor activity. In order to ensure the scientificity and reliability of the in-depth research and development of the drug, impurity analysis is particularly important for drug quality control. Jia Qiaoyun first established a reversed-phase ion-pair liquid chromatography detection method for impurities related to thio-oligonucleotide CT102 (same sequence as YK102) in "Analysis of impurities related to thio-oligonucleotide CT102 by reversed-phase ion-pair high-performance liquid chromatography" (Journal of Drug Analysis 033.007 (2013): 1157-1162, 1167). The impurity 5'(P=S / O)1 and YK102 were baseline separated, but 5'n-1 and 3'n-1 could not be effectively separated (page 1160, Figure 1 ). Therefore, there is a need in the art to develop a method with good reproducibility and the ability to stably monitor impurities in YK102. Summary of the invention
[0005] In view of the defects and deficiencies in the prior art, the present application provides a method for detecting impurities in thio-oligonucleotide YK102. The outstanding advantages of this method are: it can simultaneously separate and detect the shortened sequence (n-1) impurities and incomplete thio-sequence impurities in the YK102 raw material drug, with good reproducibility, the separation degree between the impurities and the main peak is greater than 1.5, and the separation degree between the impurities is greater than 1.2, and it can be used for the quality control of the YK102 raw material drug.
[0006] The structural formula and chemical name of each shortened sequence impurity and incomplete thio sequence impurity are shown in Table 1:
[0007] Table 1 Structural information of shortened sequence and incomplete thio sequence impurities
[0008]
[0009] Note: The position marked with "_" represents a missing base, and the position marked with "o" in the sequence represents an oxygen substitution (one oxygen in the phosphodiester bond is not replaced by sulfur).
[0010] Specifically, the present invention provides a method for detecting impurities in thio-oligonucleotide YK102 using reversed-phase ion-pair liquid chromatography, wherein the nucleotide sequence of the thio-oligonucleotide YK102 is 5'-TCCTCCGGAGCCAGACTTCA-3' (SEQ ID NO: 1), which comprises the following steps:
[0011] 1) Solution preparation: preparing a test solution with a diluent, wherein the test solution includes any one or more of YK102 and related impurities;
[0012] 2) The test solution was tested using the following chromatographic conditions, wherein the chromatographic conditions are:
[0013] Chromatographic column: The stationary phase uses octadecylsilane bonded silica gel as filler, which is a Waters XBridgeOligonucleotide BEH C18 chromatographic column;
[0014] Mobile phase A: 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine-methanol mixed solution, wherein the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 20-100mmol / L, preferably 40-60mmol / L, more preferably 50mmol / L; the concentration of N,N-dimethylbutylamine is 5-30mmol / L, preferably 10-20mmol / L, more preferably 15mmol / L; the concentration of hexylamine is 1-10mmol / L, preferably 3-7mmol / L, more preferably 5mmol / L; the volume ratio of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine to methanol is 9:1;
[0015] Mobile phase B: 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine-methanol mixed solution, wherein the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 20-100mmol / L, preferably 40-60mmol / L, more preferably 50mmol / L; the concentration of N,N-dimethylbutylamine is 5-30mmol / L, preferably 10-20mmol / L, more preferably 15mmol / L; the concentration of hexylamine is 1-10mmol / L, preferably 3-7mmol / L, more preferably 5mmol / L; the volume ratio of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine to methanol is 4:1;
[0016] Column temperature: 60-80°C, preferably 65°C;
[0017] Flow rate: 0.2-0.5 mL / min, preferably 0.3 mL / min;
[0018] Detection wavelength: 256-264 nm, preferably 260 nm;
[0019] Elution gradient:
[0020]
[0021] In a preferred embodiment, in the detection method of the present application, the elution gradient is:
[0022]
[0023] In a preferred embodiment, in the detection method of the present application, the mobile phase A is a 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine-methanol mixed solution, wherein the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 40-60 mmol / L, preferably 50 mmol / L; the concentration of N,N-dimethylbutylamine is 10-20 mmol / L, preferably 15 mmol / L; the concentration of hexylamine is 3-7 mmol / L, preferably 5 mmol / L; the volume ratio of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine to methanol is 9:1; the mobile phase B is 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine to methanol. A hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine-methanol mixed solution, wherein the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 40-60 mmol / L, preferably 50 mmol / L; the concentration of N,N-dimethylbutylamine is 10-20 mmol / L, preferably 15 mmol / L; the concentration of hexylamine is 3-7 mmol / L, preferably 5 mmol / L; and the volume ratio of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine to methanol is 4:1.
[0024] In a preferred embodiment, in the detection method of the present application, the mobile phase A is a mixed solution of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine-methanol, wherein the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 50 mmol / L; the concentration of N,N-dimethylbutylamine is 15 mmol / L; the concentration of hexylamine is 5 mmol / L; the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / The volume ratio of hexylamine to methanol is 9:1; mobile phase B is a mixed solution of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine-methanol, wherein the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 50mmol / L; the concentration of N,N-dimethylbutylamine is 15mmol / L; the concentration of hexylamine is 5mmol / L; the volume ratio of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine to methanol is 4:1.
[0025] In a preferred embodiment, in the detection method of the present application, the diluent is water or a 10% methanol solution, preferably a 10% methanol solution.
[0026] In a preferred embodiment, in the detection method of the present application, the specification of the chromatographic column is 2.1-4.6 mm×50-150 mm, preferably 2.1 mm×100 mm.
[0027] In another preferred embodiment, in the detection method of the present application, the particle size of the chromatographic column is 1.5 to 3 μm, preferably 1.7 μm.
[0028] In another preferred embodiment, in the detection method of the present application, the concentration of the test solution and the relevant impurity reference substance is 0.05-0.15 mg / mL, preferably 0.1 mg / mL.
[0029] In another preferred embodiment, in the detection method of the present application, the injection volume is 5 to 15 μL, preferably 10 μL.
[0030] Beneficial effects achieved by the present invention:
[0031] The present application provides a method for simultaneously separating and detecting shortened sequence (n-1) impurities and incomplete thio-sequence impurities in thio-oligonucleotide YK102 raw materials, which has good reproducibility, a separation degree between impurities and main peak greater than 1.5, and a separation degree between impurities greater than 1.2, and can be used for quality control of YK102 raw materials. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 This is the chromatogram of Example 1, with good separation;
[0033] Figure 2 This is the chromatogram of Example 5. DETAILED DESCRIPTION
[0034] The following examples further illustrate the content of the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and substance of the present invention, modifications or substitutions made to the methods, steps or conditions of the present invention all fall within the scope of the present invention.
[0035] Unless otherwise specified, the technical methods used in the examples are conventional methods known to those skilled in the art. In the examples, all raw materials added are commercially available conventional raw materials unless otherwise specified.
[0036] Example 1: YK102 related substance detection method 1 (optimal conditions)
[0037] The chromatographic conditions are shown in Table 2:
[0038] Table 2: Chromatographic conditions of YK102 related substances detection method 1
[0039]
[0040]
[0041] Mixed solution: Weigh appropriate amounts of YK102 and impurities, add 10% methanol to dissolve them into a solution containing approximately 0.1 mg of each impurity per 1 mL.
[0042] The results are shown in Table 3:
[0043] Table 3: Test results of test method 1
[0044] name Retention time (min) Separation 5′n-1 9.273 / 3′n-1 9.751 1.321 <![CDATA[5′(P=S / O)1]]> 10.325 1.576 YK102 10.928 1.601
[0045] As shown in Table 3, under this condition, impurity 5'(P=S / O)1 and YK102 were baseline separated, impurity 3'n-1 and 5'(P=S / O)1 were baseline separated, the separation degree of impurity 5'n-1 and 3'n-1 was 1.321, which was greater than 1.2, the separation degree between impurities and the main peak was greater than 1.5, and the separation degree between impurities was greater than 1.2 (see Figure 1 ), which meets the quality control of YK102. The mobile phase selection is: mobile phase A: 50mmol / L HFTP (1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol) / 15mmol / L DMBA (N,N-dimethylbutylamine) / 5mmol / L HA (hexylamine)-methanol (volume ratio 9:1); mobile phase B: 50mmol / L HFTP (1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol) / 15mmol / L DMBA (N,N-dimethylbutylamine) / 5mmol / L HA (hexylamine)-methanol (volume ratio 4:1).
[0046] Example 2: YK102 related substance detection method 2
[0047] The chromatographic conditions are shown in Table 4:
[0048] Table 4: Chromatographic conditions for detection method 2
[0049]
[0050] Mixed solution: Weigh appropriate amounts of YK102 and impurities, add 10% methanol to dissolve them into a solution containing approximately 0.1 mg of each impurity per 1 mL.
[0051] The results are shown in Table 5:
[0052] Table 5: Test results of test method 2
[0053] name Retention time (min) Separation 5′n-1 7.046 / 3′n-1 7.415 0.989 <![CDATA[5′(P=S / O)1]]> 8.017 1.532 YK102 8.636 1.597
[0054] From the data listed in Table 5, it can be seen that impurity 5'(P=S / O)1 and YK102 are baseline separated, impurity 3'n-1 and 5'(P=S / O)1 are baseline separated, but 5'n-1 and 3'n-1 cannot be separated. Therefore, the concentrations of the components in the mobile phase A and B aqueous phase are as shown in Table 6, which cannot effectively separate all impurities:
[0055] Table 6: Concentration of each component in the mobile phase (mmol / L)
[0056] Component name 1,1,1,3,3,3-Hexafluoro-2-methyl-2-propanol N,N-Dimethylbutylamine Hexylamine Mobile phase A 30 5 2 Mobile phase B 30 5 5
[0057] Example 3: YK102 related substance detection method 3
[0058] The chromatographic conditions are shown in Table 7:
[0059] Table 7: Chromatographic conditions for detection method 3
[0060]
[0061]
[0062] Mixed solution: The preparation process is the same as Example 1.
[0063] The results are shown in Table 8:
[0064] Table 8: Test results of test method 3
[0065] name Retention time (min) Separation 5′n-1 7.981 / 3′n-1 8.478 1.182 <![CDATA[5′(P=S / O)1]]> 9.004 1.533 YK102 9.617 1.599
[0066] As shown in Table 8, impurity 5'(P=S / O)1 and YK102 are baseline separated, and impurity 3'n-1 and 5'(P=S / O)1 are baseline separated, but the separation between 5'n-1 and 3'n-1 is poor, less than 1.2. Therefore, the concentrations of the components in mobile phase A and B aqueous phase are as shown in Table 9, and all impurities cannot be effectively separated:
[0067] Table 9: Concentration of each component in the mobile phase (mmol / L)
[0068] name 1,1,1,3,3,3-Hexafluoro-2-methyl-2-propanol N,N-Dimethylbutylamine Hexylamine Mobile phase A 50 10 3 Mobile phase B 50 10 3
[0069] Example 4: Optimization of the detection method of YK102 related substances 4
[0070] The chromatographic conditions are shown in Table 10:
[0071] Table 10: Chromatographic conditions for detection method 4
[0072]
[0073] Mixed solution: The preparation process is the same as Example 1.
[0074] The results are shown in Table 11:
[0075] Table 11: Test results of test method 4
[0076] name Retention time (min) Separation 5′n-1 7.212 / 3′n-1 7.561 0.821 <![CDATA[5′(P=S / O)1]]> 7.897 0.897 YK102 8.224 0.993
[0077] As shown in Table 11, the separation between the chromatographic peaks was poor, and none of them achieved baseline separation. Therefore, when N,N-dimethylbutylamine was not added to mobile phases A and B, and the concentrations of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol and hexylamine were 50 mmol / L and 5 mmol / L, respectively, the impurities could not be effectively separated.
[0078] Example 5: YK102 Related Substance Detection Method 5
[0079] The chromatographic conditions are shown in Table 12:
[0080] Table 12: Chromatographic conditions for detection method 5
[0081]
[0082] Mixed solution: The preparation process is the same as Example 1.
[0083] The results are shown in Table 13:
[0084] Table 13: Test results of test method 5
[0085] name Retention time (min) Separation 5′n-1 9.452 / 3′n-1 9.803 1.107 <![CDATA[5′(P=S / O)1]]> 10.323 1.413 YK102 10.861 1.480
[0086] As shown in Table 13, baseline separation was not achieved between the chromatographic peaks, and the impurities could not be separated well. Therefore, when hexylamine was not added to mobile phases A and B, and the concentrations of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol and N,N-dimethylbutylamine were 50 mmol / L and 15 mmol / L, respectively, the impurities could not be separated.
[0087] Example 6: Durability of Chromatographic Conditions for YK102 Related Substance Detection Method
[0088] The conditions for the durability test of the chromatographic conditions are shown in Table 14:
[0089] Table 14: Chromatographic conditions for durability testing
[0090]
[0091] The results of the mixed solution for durability testing are shown in Table 15:
[0092] Table 15: Results of the robustness test of chromatographic conditions
[0093]
[0094]
[0095] From the test results in Table 15, it can be seen that any of the following conditions can effectively separate the impurities 5'n-1, 3'n-1, 5'(P=S / O)1 and the main component YK102 contained in the mixed solution, and the separation degree between the impurities and the main peak is greater than 1.5, and the separation degree between the impurities is greater than 1.2, indicating that this chromatographic method has good durability:
[0096] 1) The wavelength changes by ±4nm, and other conditions remain unchanged;
[0097] 2) The flow rate is in the range of 0.3-0.4 mL / min, and other conditions remain unchanged;
[0098] 3) The HFTP concentration in the aqueous phase composition of mobile phases A and B is in the range of 45-55 mmol / L, and other conditions remain unchanged;
[0099] 4) The DMBA concentration in the aqueous phase composition of mobile phases A and B is in the range of 13-17 mmol / L, and other conditions remain unchanged;
[0100] 5) The HA concentration in the aqueous phase composition of mobile phase A and B is in the range of 4-6 mmol / L, and other conditions remain unchanged; 6) The column temperature is in the range of 60℃-70℃, and other conditions remain unchanged.
[0101] Example 7: Chromatographic Condition Specificity of YK102 Related Substance Detection Method
[0102] The chromatographic conditions are shown in Table 16:
[0103] Table 16: Chromatographic conditions for specificity evaluation of detection method
[0104]
[0105] Mixed solution: The preparation process is the same as Example 1.
[0106] Positioning solution: Weigh appropriate amounts of YK102 and impurities, add 10% methanol to dissolve them respectively to make solutions containing approximately 0.1 mg of each in 1 mL.
[0107] Table 17: Results of the specificity study of the detection method
[0108]
[0109] From the results in Table 17, it can be seen that the separation between impurities and the main peak is greater than 1.5, and the separation between impurities is greater than 1.2. The blank solvent does not interfere with the determination, and the method has good specificity.
[0110] Comparative Example:
[0111] The mixed solution was determined using the analytical method in the literature "Analysis of impurities related to sulfur oligonucleotide CT102 by reversed-phase ion-pair high performance liquid chromatography".
[0112] The chromatographic conditions are shown in Table 18:
[0113] Table 18: Comparative Chromatographic Conditions
[0114]
[0115] Mixed solution: The preparation process is the same as Example 1.
[0116] The results are shown in Table 19:
[0117] Table 19: Comparative test results
[0118] name Retention time (min) Separation 5′n-1 8.145 / 3′n-1 8.411 0.824 <![CDATA[5′(P=S / O)1]]> 8.943 1.232 YK102 9.675 1.507
[0119] As shown in Table 19, the impurity 5'(P=S / O)1 and YK102 were baseline separated, but the separation between 5'n-1 and 3'n-1 was poor, less than 1.2.
[0120] Although the present invention has been described in detail above by general description, specific implementation methods and experiments, it is obvious to those skilled in the art that some modifications or improvements can be made to the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all belong to the scope of protection claimed by the present invention. Sequence Listing <110> Hangzhou Tianlong Pharmaceutical Co., Ltd. <120> A method for detecting substances related to thio-oligonucleotides <130> PA211-246 <160> 1 <170> SIPOSequenceListing 1.0 <210> 1 <211> 20 <212> DNA <213> Artificial Sequence <400> 1 tcctccggag ccagacttca 20
Claims
1. A method for detecting impurities in thio-oligonucleotide YK102 using reverse phase ion pair liquid chromatography, wherein the nucleotide sequence of the thio-oligonucleotide YK102 is 5'-TCCTCCGGAGCCAGACTTCA-3', comprising the following steps: 1) Solution preparation: a test solution is prepared with a diluent, wherein the test solution comprises YK102 and impurities, wherein the impurities comprise a shortened sequence impurity (5'n-1) having a nucleotide sequence of 5'-CCTCCGGAGCC AGACTTCA-3', a shortened sequence impurity (3'n-1) having a nucleotide sequence of 5'-TCCTCCGGAGCCAGACTT C-3', and an incomplete thiolated impurity (5' (P=S / O)1) having a nucleotide sequence of 5'-ToCCTCCGGA GCCAGACTTCA-3', wherein o in the impurity sequence represents that an oxygen of the phosphodiester bond at that position is not replaced by sulfur; 2) The test solution was tested using the following chromatographic conditions, wherein the chromatographic conditions are: Chromatographic column: The stationary phase uses octadecylsilane bonded silica gel as filler, which is a Waters XBridgeOligonucleotide BEH C18 chromatographic column; Mobile phase A: a mixed solution of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine-methanol in a volume ratio of 9:1, wherein the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 45-55mmol / L; the concentration of N,N-dimethylbutylamine is 13-17mmol / L; the concentration of hexylamine is 4-6mmol / L; Mobile phase B: a mixed solution of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol / N,N-dimethylbutylamine / hexylamine-methanol in a volume ratio of 4:1, wherein the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 45-55mmol / L; the concentration of N,N-dimethylbutylamine is 13-17mmol / L; the concentration of hexylamine is 4-6mmol / L; Column temperature: 60~80℃; Flow rate: 0.2~0.5mL / min; Detection wavelength: 256~264nm; Elution gradient: 。 2. The method according to claim 1, wherein the column temperature is 65°C.
3. The method according to claim 1, with a flow rate of 0.3 mL / min.
4. The method according to claim 1, wherein the detection wavelength is 260 nm.
5. The method according to claim 1, wherein the chromatographic conditions are: Mobile phase A: the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 50 mmol / L; the concentration of N,N-dimethylbutylamine is 15 mmol / L; the concentration of hexylamine is 5 mmol / L; Mobile phase B: the concentration of 1,1,1,3,3,3-hexafluoro-2-methyl-2-propanol is 50 mmol / L; the concentration of N,N-dimethylbutylamine is 15 mmol / L; the concentration of hexylamine is 5 mmol / L.
6. The method according to any one of claims 1 to 5, wherein the diluent is water or a 10% methanol solution.
7. The method according to claim 6, wherein the diluent is a 10% methanol solution.
8. The method according to any one of claims 1 to 5, wherein the specification of the chromatographic column is 2.1-4.6 mm×50-150 mm.
9. The method according to claim 8, wherein the chromatographic column has a size of 2.1 mm x 100 mm.
10. The method according to any one of claims 1 to 5, wherein the particle size of the chromatographic column is 1.5 to 3 μm. The method according to claim 10 , wherein the particle size of the chromatography column is 1.7 μm.
12. The method according to any one of claims 1 to 5, wherein the concentration of the test solution is 0.05-0.15 mg / mL.
13. The method according to claim 12, wherein the concentration of the test solution is 0.1 mg / mL.
14. The method according to any one of claims 1 to 5, wherein the injection volume is 5 to 15 μL. The method according to claim 14 , wherein the injection volume is 10 μL.
